Clinical Trial Update: Ketamine for Postherpetic Neuralgia With Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ketamine for individuals with depression and postherpetic neuralgia; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postherpetic Neuralgia

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Depression Disorders, Herpetic Neuralgia | Phase 4 | Status: NOT_YET_RECRUITING